The Relationship of Opioid Misuse and Suicidality Among Adolescents With Disabilities

Abstract

Adolescents experience higher risk for opioid misuse and suicide, and those with disabilities are disproportionately vulnerable to suicide risk. Using secondary data, this study presents findings on nonmedical prescription opioid use (NMPOU) and suicidality among adolescents with and without disabilities (N = 10,676). Results indicated NMPOU was associated with higher odds for serious thoughts of suicide. Having a disability was associated with higher odds for having a plan for suicide and having a suicide attempt. Adolescents with disabilities who engaged in NMPOU had over 3 times the likelihood for serious thoughts of suicide. Social work services can be tailored for adolescents with disabilities within the context of the family unit to address the impact of the opioid epidemic using a disability-oriented framework.

Keywords

opioids suicide disability substance use adolescence

Get full access to this article

View all access options for this article.

References

Ahmad

F. B.

Anderson

R. N.

(2021). The leading causes of death in the US for 2020. JAMA, 325(18), 1829–1830. https://doi.org/10.1001/jama.2021.5469

Altman

B. M.

(2016). International measurement of disability: Purpose, method, and application. Springer.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.).

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).

American Society of Addiction Medicine. (2016). Opioid addiction 2016 facts & figures [Fact sheet]. https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf

Baiden

Graaf

Zaami

Acolatse

C. K.

Adeku

(2019). Examining the association between prescription opioid misuse and suicidal behaviors among adolescent high school students in the United States. Journal of Psychiatric Research, 112, 44–51. https://doi.org/10.1016/j.jpsychires.2019.02.018

Becker

W. C.

Fiellin

D. A.

Desai

R. A.

(2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates. Drug and Alcohol Dependence, 90(2–3), 280–287. http://doi.org/10.1016/j.drugalcdep.2007.04.009

Bellos

Skapinakis

Rai

Zitko

Araya

Lewis

Lionis

Mavreas

(2013). Cross-cultural patterns of the association between varying levels of alcohol consumption and the common mental disorders of depression and anxiety: Secondary analysis of the WHO collaborative study on psychological problems in general health care. Drug and Alcohol Dependence, 133(3), 825–831. https://doi.org/10.1016/j.drugalcdep.2013.08.030

Bewley

T. H.

Ben-Arie

James

I. P.

(1968). Morbidity and mortality from heroin dependence: Survey of heroin addicts known to home office. British Medical Journal, 1, 725–726. https://doi.org/10.1136/bmj.1.5594.725

10.

Bohnert

A. S.

Ilgen

M. A.

(2019). Understanding links among opioid use, overdose, and suicide. New England Journal of Medicine, 380(1), 71–79. https://doi.org/10.1056/NEJMra1802148

11.

Bridge

J. A.

Ruch

D. A.

Sheftall

A. H.

Hahm

H. C.

O’Keefe

V. M.

Fontanella

C. A.

Brock

Campo

J. V.

Horowitz

L. M.

(2023). Youth suicide during the first year of the COVID-19 pandemic. Pediatrics, 151(3), Article e2022058375. https://doi.org/10.1542/peds.2022-058375

12.

Cash

S. J.

Bridge

J. A.

(2009). Epidemiology of youth suicide and suicidal behavior. Current Opinion in Pediatrics, 21(5), 613–619. https://doi.org/10.1097/MOP.0b013e32833063e1

13.

Center for Behavioral Health Statistics and Quality. (2020). 2019 National Survey on Drug Use and Health: Public use file codebook. Substance Abuse and Mental Health Services Administration.

14.

Centers for Disease Control and Prevention. (2018a). CDC: 1 in 4 US adults live with a disability. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2018/p0816-disability.html

15.

Centers for Disease Control and Prevention. (2018b). Leading causes of death by age group. https://www.cdc.gov/injury/images/lc-charts/leading_causes_of_death_by_age_group_2018_1100w850h.jpg

16.

Centers for Disease Control and Prevention. (2021). WISQARS. Leading causes of death reports 1981-2020. https://www.cdc.gov/injury/wisqars/index.html

17.

Centers for Disease Control and Prevention. (2023). Youth risk behavior survey data summary & trends report: 2011-2021. https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm

18.

Centers for Disease Control and Prevention, National Center for Health Statistics. (2021). Drug overdose deaths in the U.S. top 100,000 annually. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm

19.

Cha

C. B.

Franz

P. J. M.

Guzmán

Glenn

C. R.

Kleiman

E. M.

Nock

M. K.

(2018). Annual research review: Suicide among youth–epidemiology, (potential) etiology, and treatment. Journal of Child Psychology and Psychiatry, 59(4), 460–482. https://doi.org/10.1111/jcpp.12831

20.

Chan

K. T.

Algood

Prifti

Zidan

(2021). Cross-cultural measurement invariance of a measure of disability for White, Black, Hispanic and Asian older adults. International Journal of Environmental Research and Public Health, 18(4), 1401. https://doi.org/10.3390/ijerph18041401

21.

Chan

K. T.

Marsack-Topolewski

C. N.

(2020). Gender differences in adolescent opioid misuse and major depressive episodes. Child and Adolescent Social Work Journal, 37, 397–409. https://doi.org/10.1007/s10560-019-00642-7

22.

Chan

K. T.

Marsack-Topolewski

C. N.

(2023). The association of opioid misuse and suicidality among people with disabilities. Substance Use & Misuse, 58(1), 1–10. https://doi.org/10.1080/10826084.2022.2125271

23.

Chan

K. T.

Winston

Jennings

Trant

Moller

(2019). Age differences in the association of nonmedical prescription opioid use and suicidality. Journal of Opioid Management, 15(1), 5–10. https://doi.org/10.5055/jom.2019.0480

24.

Chan

K. T.

Zhou

Marsack-Topolewski

(2022). Race differences in opioid misuse and adolescent suicidality. Child and Adolescent Social Work Journal, 39(2), 167–181. https://doi.org/10.1007/s10560-020-00721-0

25.

Choi

J. W.

Lee

K. S.

Han

(2020). Psychiatric disorders and suicide risk among adults with disabilities: A nationwide retrospective cohort study. Journal of Affective Disorders, 263, 9–14. https://doi.org/10.1016/j.jad.2019.11.129

26.

Chung

C. P.

Callahan

S. T.

Cooper

W. O.

Dupont

W. D.

Murray

K. T.

Franklin

A. D.

. . . Ray

W. A.

(2018). Outpatient opioid prescriptions for children and opioid-related adverse events. Pediatrics, 142, Article e20172156. https://doi.org/10.1542/peds.2017-2156

27.

Clayton

H. B.

Bohm

M. K.

Lowry

Ashley

Ethier

K. A.

(2019). Prescription opioid misuse associated with risk behaviors among adolescents. American Journal of Preventive Medicine, 57(4), 533–539. https://doi.org/10.1016/j.amepre.2019.05.017

28.

Coben

J. H.

Davis

S. M.

Furbee

P. M.

Sikora

R. D.

Tillotson

R. D.

Bossarte

R. M.

(2010). Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. American Journal of Preventive Medicine, 38, 517–524. https://doi.org/10.1016/j.amepre.2010.01.022

29.

Cree

R. A.

Okoro

C. A.

Zack

M. M.

Carbone

(2020). Frequent mental distress among adults by disability status, disability type, and selected characteristics—United States 2018. Morbidity and Mortality Weekly Report (MMWR). https://www.cdc.gov/mmwr/volumes/69/wr/mm6936a2.htm

30.

Crossin

Cairney

Lawrence

A. J.

Duncan

J. R.

(2017). Adolescent inhalant abuse leads to other drug use and impaired growth: Implications for diagnosis. Australian and New Zealand Journal of Public Health, 41, 99–104. https://doi.org/10.1111/1753-6405.12595

31.

Dash

G. F.

Wilson

A. C.

Morasco

B. J.

Feldstein Ewing

S. W.

(2018). A model of the intersection of pain and opioid misuse in children and adolescents. Clinical Psychological Science: A Journal of the Association for Psychological Science, 6(5), 629–646. https://doi.org/10.1177/2167702618773323

32.

De Gregorio

Aguilar-Valles

Preller

K. H.

Heifets

B. D.

Hibicke

Mitchell

Gobbi

. (2021). Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 41(5), 891–900. https://doi.org/10.1523/JNEUROSCI.1659-20.2020

33.

DeShazo

R. D.

Parker

S. B.

Williams

Ingram

J. B.

Elsohly

Rodenmeyer

McCullouch

(2019). Marijuana’s effects on brain structure and function: What do we know and what should we do? A brief review and commentary. The American Journal of Medicine, 132(3), 281–285. https://doi.org/10.1016/j.amjmed.2018.09.006

34.

Dubovis

Muneyyirci-Delale

(2020). Effects of marijuana on human reproduction. Reproductive Toxicology, 94, 22–30. https://doi.org/10.1016/j.reprotox.2020.04.071

35.

Eccleston

Wastell

Crombez

Jordan

(2008). Adolescent social development and chronic pain. European Journal of Pain, 12(6), 765–774. https://doi.org/10.1016/j.ejpain.2007.11.002

36.

Ferro

M. A.

Rhodes

A. E.

Kimber

Duncan

Boyle

M. H.

Georgiades

. . . MacMillan

H. L.

(2017). Suicidal behaviour among adolescents and young adults with self-reported chronic illness. The Canadian Journal of Psychiatry, 62(12), 845–853. https://doi.org/10.1177/0706743717727242

37.

Goering

(2015). Rethinking disability: The social model of disability and chronic disease. Current Reviews in Musculoskeletal Medicine, 8(2), 134–138. https://doi.org/10.1007/s12178-015-9273-z

38.

Graham

Schultz

Mont

(2017). Disability in middle childhood and adolescence. In Bundy

de Silva

Horton

Jamison

D. T.

Patton

G. C.

(Eds.), Child and adolescent health and development (pp. 221–238). The International Bank for Reconstruction and Development; Springer.

39.

Grella

C. E.

Lovinger

(2012). Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addictive Behaviors, 37(3), 306–312. https://doi.org/10.1016/j.addbeh.2011.11.028

40.

Griesler

P. C.

M. C.

Wall

M. M.

Kandel

D. B.

(2019). Nonmedical prescription opioid use by parents and adolescents in the US. Pediatrics, 143, 1–10. https://doi.org/10.1542/peds.2018-2354

41.

Guo

Deng

Huang

Gao

Pan

Zhang

W. H.

(2016). Association between nonmedical use of prescription drugs and suicidal behavior among adolescents. JAMA Pediatrics, 170(10), 971–978. https://doi.org/10.1001/jamapediatrics.2016.1802

42.

Hendy

H. M.

Black

Can

S. H.

Fleischut

Aksen

(2018). Opioid abuse as maladaptive coping to life stressors in US adults. Journal of Drug Issues, 48(4), 560–571. https://doi.org/10.1177/0022042618783454

43.

Heron

M. P.

(2017). Deaths: Leading causes for 2015. National Vital Statistics Reports, 66(5), 1–76. https://www-cdc-gov.ezproxy.emich.edu/nchs/data/nvsr/nvsr66/nvsr66_05.pdf

44.

Hong

Geraci

Turk

M. A.

Love

B. L.

McDermott

S. W.

(2019). Opioid prescription patterns for adults with longstanding disability and inflammatory conditions compared to other users, using a nationally representative sample. Archives of Physical Medicine and Rehabilitation, 100(1), 86–94. https://doi.org/10.1016/j.apmr.2018.06.034

45.

Hudgins

J. D.

Porter

J. J.

Monuteaux

M. C.

Bourgeois

F. T.

(2019). Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS Medicine, 16(11), Article e1002922. https://doi.org/10.1371/journal.pmed.1002922

46.

Kann

McManus

Harris

W. A.

Shanklin

S. L.

Flint

K. H.

Hawkins

Queen

Lowry

O’Malley Olsen

Chyen

Whittle

Thornton

Lim

Yamakawa

Brener

Zaza

(2016). Youth risk behavior surveillance—United States, 2015. MMWR: Surveillance Summaries, 65(6), 1–174. https://doi.org/10.15585/mmwr.ss6506a1

47.

Kennedy

Burley

Roll

(2018). The prevalence and treatment of opioid misuse among working-age adults with disabilities, 2016. Accessed at the website from a NIDILRR project containing information on opioid misuse. https://www.chril.org/new-blog/2018/4/12/the-prevalence-and-treatment-of-opioid-misuse-among-working-age-adults-with-disabilities-2016

48.

Khazem

L. R.

Jahn

D. R.

Cukrowicz

K. C.

Anestis

M. D

. (2017). Health conditions, physical disabilities, perceived burdensomeness, and depressive symptoms influence suicidal ideation. Death Studies, 41(4), 220–225. https://doi.org/10.1080/07481187.2016.1251509

49.

Klimas

Gorfinkel

Fairbairn

Amato

Ahamad

Nolan

. . . Wood

(2019). Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: A systematic review. JAMA Network Open, 2(5), Article e193365. https://doi.org/10.1001/jamanetworkopen.2019.3365

50.

Lal

Tremblay

Starcevic

Mauger-Lavigne

Anaby

(2022). Mental health problems among adolescents and young adults with childhood-onset physical disabilities: A scoping review. Frontiers in Rehabilitation Sciences, 3, Article 904586. https://doi.org/10.3389/fresc.2022.904586

51.

Lauer

E. A.

Henly

Brucker

D. L.

(2019). Prescription opioid behaviors among adults with and without disabilities–United States, 2015–2016. Disability and Health Journal, 12(3), 519–522. https://doi.org/10.1016/j.dhjo.2018.12.001

52.

Lazarus

R. S.

(1993). Coping theory and research: Past, present, and future. In Lazarus

R. S.

(Ed.) Fifty years of the research and theory of RS Lazarus: An analysis of historical and perennial issues (1st ed., pp. 366–388). Psychology Press.

53.

Lazarus

R. S

Folkman

(1984). Stress, appraisal, and coping. Springer.

54.

Lewis

V. M.

Williams

Koko

Woolmore

Jones

Powell

. (2017). Disability, depression and suicide ideation in people with multiple sclerosis. Journal of Affective Disorders, 208, 662–669. https://doi.org/10.1016/j.jad.2016.08.038

55.

Maxey

Beckert

T. E.

(2017). Adolescents with disabilities. Adolescent Research Review, 2, 59–75. https://doi.org/10.1007/s40894-016-0043-y

56.

Mayes

S. D.

Calhoun

S. L.

Baweja

Mahr

(2015). Suicide ideation and attempts in children with psychiatric disorders and typical development. Crisis: The Journal of Crisis Intervention and Suicide Prevention, 36(1), 55–60. https://doi.org/10.1027/0227-5910/a000284

57.

McCabe

S. E.

West

B. T.

Veliz

McCabe

V. V.

Stoddard

S. A.

Boyd

C. J.

(2017). Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976-2015. Pediatrics, 139(4), 1–9. https://doi.org/10.1542/peds.2016-2387

58.

Meltzer

Brugha

Dennis

M. S.

Hassiotis

Jenkins

McManus

Rai

Bebbington

(2012). The influence of disability on suicidal behaviour. Alter, 6(1), 1–12. https://doi.org/10.1016/j.alter.2011.11.004

59.

Merikangas

K. R.

Ames

Cui

Stang

P. E.

Ustun

T. B.

Von Korff

Kessler

R. C.

(2007). The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Archives of General Psychiatry, 64(10), 1180–1188. https://doi.org/10.1001/archpsyc.64.10.1180

60.

Minnes

Min

M. O.

Singer

L. T.

Edguer

Thi

(2012). Cocaine use during pregnancy and health outcome after 10 years. Drug and Alcohol Dependence, 126, 71–79. https://doi.org/10.1016/j.drugalcdep.2012.04.015

61.

Morden

N. E.

Munson

J. C.

Colla

C. H.

Skinner

J. S.

Bynum

J. P.

Zhou

Meara

E. R.

(2014). Prescription opioid use among disabled Medicare beneficiaries: Intensity, trends and regional variation. Medical Care, 52(9), 852–859. https://doi.org/10.1097/MLR.0000000000000183

62.

Moses

(2018). Suicide attempts among adolescents with self-reported disabilities. Child Psychiatry & Human Development, 49(3), 420–433. https://doi.org/10.1007/s10578-017-0761-9

63.

National Academies of Sciences, Engineering, and Medicine. (2017). The health efects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. https://doi.org/10.17226/24625.

64.

National Institute on Disability, Independent Living, and Rehabilitation Research. (2018). Summary of response from a request for information: People with disabilities and opioid use disorder.

65.

National Institute on Drug Abuse. (2015). Hallucinogens and dissociative drugs. https://www.drugabuse.gov/publications/hallucinogens-dissociative-drugs/how-do-hallucinogens-lsd-psilocybin-peyote-dmt-ayahuasca-affect-brain-body

66.

O’Connor

M. J.

Portnoff

L. C.

Lebsack-Coleman

Dipple

K. M.

(2019). Suicide risk in adolescents with fetal alcohol spectrum disorders. Birth Defects Research, 111(12), 822–828. https://doi.org/10.1002/bdr2.1465

67.

Paige

K. J.

Colder

C. R.

(2020). Long-term effects of early adolescent marijuana use on attentional and inhibitory control. Journal of Studies on Alcohol and Drugs, 81(2), 164–172. https://doi.org/10.15288/jsad.2020.81.164

68.

Palmer

Harley

(2011). Models and measurement in disability: An international review. Health Policy and Planning, 27(5), 357–364. https://doi.org/10.1093/heapol/czr047

69.

Peter

Roberts

L. W.

Buzdugan

(2008). Suicidal ideation among Canadian youth: A multivariate analysis. Archives of Suicide Research, 12(3), 263–275. https://doi.org/10.1080/13811110802100882

70.

Phelan

J. C.

Link

B. G.

Ana Diez-Roux Kawachi

Levin

(2004). “Fundamental causes” of social inequalities in mortality: A test of the theory. Journal of Health and Social Behavior, 45(3), 265–285. https://doi.org/10.1177/002214650404500303

71.

Russell

Turner

R. J.

Joiner

T. E.

(2009). Physical disability and suicidal ideation: A community-based study of risk/protective factors for suicidal thoughts. Suicide and Life-Threatening Behavior, 39(4), 440–451. https://doi.org/10.1521/suli.2009.39.4.440

72.

Sheridan

D. C.

Laurie

Hendrickson

R. G.

Kea

Horowitz

B. Z.

(2016). Association of overall opioid prescriptions on adolescent opioid abuse. The Journal of Emergency Medicine, 51, 485–490. https://doi.org/10.1016/j.jemermed.2016.06.049

73.

Smart

R. G.

(1991). Crack cocaine use: A review of prevalence and adverse effects. The American Journal of Drug and Alcohol Abuse, 17, 13–26. https://doi.org/10.3109/00952999108992806

74.

Sommers

Baskin

Baskin-Sommers

(2006). Methamphetamine use among young adults: Health and social consequences. Addictive Behaviors, 31, 1469–1476. https://doi.org/10.1016/j.addbeh.2005.10.004

75.

StataCorp. (2016). Stata statistical software: Release 15.

76.

Stoep

A. V.

McCauley

Flynn

Stone

(2009). Thoughts of death and suicide in early adolescence. Suicide & Life-threatening Behavior, 39(6), 599–613. https://doi.org/10.1521/suli.2009.39.6.599

77.

Substance Abuse and Mental Health Services Administration. (2018). Reports and detailed tables from the 2017 National Survey on Drug Use and Health. https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2017-NSDUH

78.

Substance Abuse and Mental Health Services Administration. (2022). Substance abuse and mental health data archive. https://www.datafiles.samhsa.gov/

79.

Suris

Michaud

Viner

(2004). The adolescent with a chronic condition. Part I: Developmental issues. Archives of Disease in Childhood, 89(10), 938–942. https://doi.org/10.1136/adc.2003.045369

80.

United Nations Statistics Division. (2017). Washington group on disability statistics homepage. https://unstats.un.org/unsd/methods/citygroup/washington.htm

81.

Washington Group on Disability Statistics. (2017). WG conceptual framework. http://www.washingtongroup-disability.com/methodology-and-research/conceptual-framework/

82.

World Health Organization. (2022). Social determinants of health. https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1

83.

Zullig

K. J.

Divin

A. L.

(2012). The association between non-medical prescription drug use, depressive symptoms, and suicidality among college students. Addictive Behaviors, 37(8), 890–899. https://doi.org/10.1016/j.addbeh.2012.02.008

84.

Zullig

K. J.

Divin

A. L.

Weiler

R. M.

Haddox

J. D.

Pealer

L. N.

(2015). Adolescent nonmedical use of prescription pain relievers, stimulants, and depressants, and suicide risk. Substance Use & Misuse, 50(13), 1678–1689. https://doi.org/10.3109/10826084.2015.1027931